Kobo Biotech

2.88
-0.12
(-4.00%)
Market Cap
6.91 Cr
EPS
-15.47
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
5.11
52 Week Low
2.51
PB Ratio
-0.05
Debt to Equity
2.56
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
826.45
#1 21,054.33
49.69
#1 15,707.00
-7.64
449
-110.82
44.46
1,309.30
16,528.32
19.12
8,798.90
-22.71
457
#1 318.35
67.00
487.60
7,164.83
14.52
8,398.90
-20.68
485
68.04
44.72
433.30
6,850.89
-
4,003.40
-20.27
-158
45.41
48.16
599.50
5,740.50
#1 9.94
3,498.80
-23.68
#1 794
68.74
43.75
768.90
4,905.73
-
21.50
#1 10,650.00
2
62.50
41.64
622.90
4,574.90
-
3,896.70
-14.52
-237
90.27
52.82
3,487.65
3,478.94
42.19
385.20
0.60
53
244.55
68.21
86.44
3,053.07
25.44
1,099.90
9.90
146
0.70
47.70
255.76
2,618.68
-
2,102.50
-2.77
-39
-82.61
49.33
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-99.07 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
TTM
Revenue
103
0
Expenses
104
0
EBITDA
-1
0
Operating Profit %
-1 %
0 %
Depreciation
10
0
Interest
24
0
Profit Before Tax
-34
0
Tax
1
0
Net Profit
-35
0
EPS in ₹
-15.47
0.00

Balance Sheet

Balance Sheet
2015
Total Assets
396
Fixed Assets
104
Current Assets
290
Capital Work in Progress
2
Investments
0
Other Assets
290
Total Liabilities
396
Current Liabilities
264
Non Current Liabilities
79
Total Equity
53
Reserve & Surplus
31
Share Capital
23

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Cash Flow
-1
0
-1
0
0
0
1
-1
0
Investing Activities
0
0
0
0
0
0
0
25
0
Operating Activities
19
6
32
32
21
15
3
94
1
Financing Activities
-21
-5
-33
-32
-21
-15
-1
-120
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Promoter
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
44.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
0.66 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
46.99 %
46.95 %
47.02 %
46.84 %
46.81 %
46.81 %
46.65 %
46.65 %
47.70 %
47.75 %
47.86 %
47.97 %
48.27 %
Others
7.40 %
7.43 %
7.37 %
7.55 %
7.57 %
7.57 %
7.74 %
7.74 %
6.69 %
6.64 %
6.53 %
6.42 %
6.12 %
No of Share Holders
0
5,632
5,611
5,645
5,862
6,064
6,064
6,204
6,496
6,458
6,478
6,530
6,767

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Corporate Insolvency Resolution Process (CIRP)-Invitation of Resolution PlanFeb 13, 2025
Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsFeb 13, 2025
Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)Feb 11, 2025
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsNov 20, 2024
Corporate Insolvency Resolution Process (CIRP)-List of CreditorsNov 05, 2024
Corporate Insolvency Resolution Process (CIRP)-Public AnnouncementNov 05, 2024
Corporate Insolvency Resolution Process (CIRP)-Appointment of Interim Resolution Professional (IRP)Nov 05, 2024
Corporate Insolvency Resolution Process (CIRP)-Initiation of Corporate Insolvency Resolution Process (CIRP) by Financial CreditorsNov 05, 2024
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsOct 10, 2024
Corporate Insolvency Resolution Process (CIRP)-Admission of application by TribunalAug 16, 2024
Unaudited Financial Results For The Quarter Ended 30Th June, 2024.Aug 14, 2024
Board Meeting Intimation for Board Meeting For The Approval Of Unaudited Financial Statement For The Quarter Ended 30Th June, 2024Aug 12, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 20, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJun 28, 2024
Closure of Trading WindowJun 26, 2024
Stay On The NCLT Order Dated 15Th May, 2024 Of M/S. Arch Pharmalabs Limited (Promoter Entity)May 31, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 30, 2024
Audited Financial Results For The Quarter And Year Ended 31St March, 2024.May 30, 2024
Board Meeting Outcome for Submission Of The Audited Financial Results For The Quarter And The Year Ended 31St March, 2024 Along With The Report Of Statutory Auditor Thereon.May 30, 2024
Board Meeting Intimation for Approval Of Financial StatementMay 23, 2024
Admission Of Application Under Section 7 Of Insolvency And Bankruptcy Code, 2016 Against M/S. Arch Pharmalabs Limited (Promoter Entity)May 17, 2024
Compliance Certificate Under Regulation 7(3)Apr 26, 2024
Certificate Pursuant To Regulation 40(9) Of SEBI LODRApr 20, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 20, 2024
Closure of Trading WindowMar 28, 2024
Financial Result For The Quarter And Nine Months Ended 31St December, 2023Feb 14, 2024
Board Meeting Intimation for Approval Of The Unaudited Financial Statements For The Quarter And Nine Months Ended 31St December 2023.Feb 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 23, 2024
Closure of Trading WindowDec 28, 2023
Related Party Transaction For The Hald Year Ended 30-09-2023Nov 10, 2023
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2023Nov 10, 2023
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday, 10Th November, 2023.Nov 03, 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 17, 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 03, 2023
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2023
Closure of Trading WindowSep 30, 2023
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2023
Reg. 34 (1) Annual Report.Sep 09, 2023
30Th Annual Report For The Financial Year 2022-23Sep 09, 2023
Notice Of The 30Th Annual General Meeting Of The Company For The Financial Year 2022-23 To Be Held On Saturday, The 30Th Day Of September, 2023 At 10.00 A.MSep 09, 2023
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 11, 2023
Unaudited Financial Results For The Quarter Ended 30Th June, 2023.Aug 11, 2023
Board Meeting Outcome for OUTCOME OF THE BOARD MEETINGAug 11, 2023
Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The 1St Quarter Ended 30Th June, 2023.Aug 03, 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 15, 2023
Closure of Trading WindowJun 30, 2023
Compliances-Reg.24(A)-Annual Secretarial ComplianceJun 01, 2023
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2023
Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2023May 30, 2023

Technical Indicators

RSI(14)
Neutral
46.95
ATR(14)
Volatile
0.24
STOCH(9,6)
Neutral
51.34
STOCH RSI(14)
Neutral
30.46
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
18.75
UO(9)
Bearish
43.25
ROC(12)
Downtrend But Slowing Down
-8.28
WillR(14)
Neutral
-75.32